This informative webinar offers a comprehensive overview of bladder cancer. Hosted by Dr. Paul Toren, this session covers key aspects of the disease, including risk factors, symptoms, diagnosis, staging, grading, and treatment options for various types of bladder cancer. Whether you’re newly diagnosed or caring for someone with bladder cancer, this webinar will equip you with the essential knowledge to navigate a bladder cancer diagnosis.
Understanding Bladder Cancer and Its Risk Factors
Bladder cancer is the fifth most common cancer in Canada, with about 13,000 new cases annually. Early detection is crucial for better outcomes. Major risk factors include male biological sex, smoking (the most significant modifiable factor), chronic bladder irritation, chemical exposures, certain chemotherapy agents, and rare genetic syndromes. Symptoms often include blood in the urine, frequent urination, urgency, or pain during urination. Advanced disease may cause pelvic pain, swollen lymph nodes, or weight loss.
Diagnosis, Staging, and Classification of Bladder Cancer
Bladder cancer is primarily diagnosed through cystoscopy, which allows visualization and biopsy of tumors. Imaging, such as CT scans or ultrasound, can supplement diagnosis. Tumors are classified by stage (depth and spread) and grade (aggressiveness). Types include:
- Non-muscle invasive bladder cancer (NMIBC): Confined to inner layers; high recurrence but generally good prognosis.
- Muscle-invasive bladder cancer (MIBC): Invades the bladder muscle; higher risk of spread.
- Advanced/metastatic bladder cancer: Spread beyond the bladder.
- Upper tract urothelial carcinoma: Occurs in the ureters or kidneys.
Treatment Options for Bladder Cancer
Bladder cancer treatment depends on cancer type, stage, and patient factors. NMIBC is typically treated with TURBT (surgical tumor removal) and intravesical therapy (BCG or chemotherapy instilled into the bladder). MIBC or refractory cases (when the cancer does not respond to treatment) may require radical cystectomy with a urinary diversion (ileal conduit, neobladder, or Indiana pouch). Other options include radiation, systemic chemotherapy, and for advanced disease, immunotherapy or targeted therapies. Personalized care from a multidisciplinary team is essential to manage side effects and optimize quality of life.
Emerging Bladder Cancer Therapies and Clinical Trials
Clinical trials explore new approaches such as sustained-release chemotherapy gels, cancer-killing (oncolytic) viruses, and combination therapies. Participation may provide early access to innovative treatments and improved outcomes.
Get Support and Resources Through Bladder Cancer Canada
Early detection, personalized treatment, and ongoing surveillance are critical. Get involved with Bladder Cancer Canada and explore educational resources, peer support, and expert guidance designed to help bladder cancer patients and caregivers navigate diagnosis, treatment, and life after bladder cancer. By accessing these resources, bladder cancer patients and families can feel more informed, supported, and empowered throughout their journey.
